Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on March 28, 2025
Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS
GlobeNewswire
·
March 28, 2025
RIPSA interests repurchased Term loan facility increased to $450 million with more favorable terms Access to up to an additional $200 million LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or …
Aya Gold & Silver Reports Q4 and Full Year 2024 Results; Announces 2025 Production and Cost Guidance
GlobeNewswire
·
March 28, 2025
MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced financial and operational results for the fourth quarter and full year ended December 31, 2024. All amounts are in US …
Aya Or & Argent annonce ses résultats pour le T4 et l’exercice 2024 et présente ses prévisions pour 2025 en termes de production et de coûts
GlobeNewswire
·
March 28, 2025
MONTRÉAL, 28 mars 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a annoncé aujourd’hui ses résultats financiers et opérationnels pour le quatrième trimestre et l’exercice financier terminés le 31 …
FDA Issues Complete Response Letter for Etripamil for PSVT
GlobeNewswire
·
March 28, 2025
CRL focused on CMC; no clinical issues relating to etripamil raised $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024 MONTREAL and CHARLOTTE, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. ( …
Director/PDMR Shareholding
GlobeNewswire
·
March 28, 2025
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU AND UK MARKET ABUSE REGIME 1. Details of the person discharging managerial responsibilities/person closely …
Europe-Wide Launch of Interventional Ultrasonic Endoscope
GlobeNewswire
·
March 28, 2025
RATINGEN, Germany, March 28, 2025 (GLOBE NEWSWIRE) -- The FUJIFILM Healthcare Europe Team are delighted to announce the Europe-wide release of the EG-740UT interventional Ultrasonic Endoscope with enhanced visibility, manoeuvrability and single crystal …
Aura Minerals Successfully Starts Ramp-Up at Borborema, On Schedule, Within Budget, and Setting an ESG Benchmark
GlobeNewswire
·
March 28, 2025
ROAD TOWN, British Virgin Islands, March 28, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to announce that production ramp-up at its Borborema Mine (“Borborema” or “Mine”) has …
ProvaDent Reviews (Is It Safe And Legit?) Investigative Report On Ingredients, Side Effects, And Benefits!
GlobeNewswire
·
March 28, 2025
TALLMADGE, Ohio, March 28, 2025 (GLOBE NEWSWIRE) -- ProvaDent is precisely fabricated to support oral health by promoting a balanced oral microbiome. It works to encourage the growth of beneficial bacteria while reducing harmful ones. Maintaining this …
2024 Full Year Financial Results
GlobeNewswire
·
March 28, 2025
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") 2024 Full Year Financial Results 2024 - a pivotal year marking the transition from developer to producer at our flagship Nalunaq mine TORONTO, ONTARIO – 28 March 2025 – Amaroq …
Ársuppgjör Amaroq Minerals 2024
GlobeNewswire
·
March 28, 2025
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) -- Ársuppgjör Amaroq Minerals 2024 Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ) birtir í dag uppgjör fyrir fjórða ársfjórðung 2024 sem og árið 2024 í heild. Stjórnendur félagsins kynna uppgjörið á fundi …
Significant Increase in Nalunaq Mineral Resource Estimate
GlobeNewswire
·
March 28, 2025
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Significant Increase in Nalunaq Mineral Resource Estimate **51% Growth in Contained Gold and Inclusion of Maiden Indicated Resources** TORONTO, ONTARIO – March …
Uppfært auðlindamat sýnir fram á verulega aukningu gullmagns í Nalunaq
GlobeNewswire
·
March 28, 2025
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) -- Uppfært auðlindamat sýnir fram á verulega aukningu gullmagns í Nalunaq **51% aukning í gullmagni í rúmar 484 þúsund únsur** Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ) tilkynnir með ánægju uppfært …
JDE Peet’s receives Fair Pay Leader certification
GlobeNewswire
·
March 28, 2025
PRESS RELEASE Amsterdam, March 28, 2025 Certification Recognizes Company’s Achievements and Commitment to Pay Equity JDE Peet’s, the world’s leading pure play coffee and tea company, has been awarded the prestigious Fair Pay Leader certification by the …
Appointment within the Societe Generale Group
GlobeNewswire
·
March 28, 2025
APPOINTMENT WITHIN THE SOCIETE GENERALE GROUP Press release Paris, 28 March 2025 Societe Generale announces the appointment of Alexis Kohler as Executive Vice President. He will join the Bank in June 2025 and will be a member of the Group Executive …
Nomination au sein du groupe Société Générale
GlobeNewswire
·
March 28, 2025
NOMINATION AU SEIN DU GROUPE SOCIÉTÉ GÉNÉRALE Communiqué de presse Paris, le 28 mars 2025 Société Générale annonce la nomination d’Alexis Kohler en tant que Directeur général adjoint du Groupe. Il rejoindra la Banque en juin 2025 et sera membre du Comité …
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
GlobeNewswire
·
March 28, 2025
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adults with elevated eosinophils Approval marks the first …
Communiqué de presse : Le Dupixent devient le tout premier biomédicament approuvé au Japon pour le traitement de la BPCO
GlobeNewswire
·
March 28, 2025
Le Dupixent devient le tout premier biomédicament approuvé au Japon pour le traitement de la BPCO Cette approbation fait suite à celle obtenue récemment dans l’Union européenne, en Chine et aux États-Unis et repose sur les résultats pivots de phase III …
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
GlobeNewswire
·
March 28, 2025
Châtillon, France, March 27, 2025 DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved DBV secures $125.5 …
DBV Technologies Annonce un Financement pouvant atteindre 306,9 millions de dollars (284,5 millions d’euros) permettant d’avancer le programme Viaskin® Peanut jusqu’au dépôt d'une Demande de Licence Biologique (BLA) et d’assurer la...
GlobeNewswire
·
March 28, 2025
Châtillon, France, le 28 mars (3h30 CET) 2025 DBV Technologies Annonce un Financement pouvant atteindre 306,9 millions de dollars (284,5 millions d’euros) permettant d’avancer le programme Viaskin® Peanut jusqu’au dépôt d'une Demande de Licence Biologique …
Update on the Langer Heinrich Mine and Production Guidance
GlobeNewswire
·
March 28, 2025
PERTH, Australia, March 27, 2025 (GLOBE NEWSWIRE) -- Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (Paladin or the Company) advises that operations have resumed at the Langer Heinrich Mine (LHM) following the temporary suspension due to a significant …